CD99 expression in Merkel cell carcinoma: A case series with an unusual paranuclear dot-like staining pattern

Journal of Cutaneous Pathology

Volumn 40, Issue 1, 2013, Pages 19-24

  Rajagopalan, Ashwyn ^a   Browning, Debra ^a   Salama, Samih ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

CD99; CK20; immunohistochemistry; Merkel cell carcinoma; paranuclear dot like staining

Indexed keywords

ANTIBODY; CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CYTOKERATIN 20; LEUKOCYTE ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MERKEL CELL TUMOR; METABOLISM; MIDDLE AGED; NEUROECTODERM TUMOR; PATHOLOGY; SKIN TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS, CD; CARCINOMA, MERKEL CELL; CELL ADHESION MOLECULES; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROECTODERMAL TUMORS, PRIMITIVE; SKIN NEOPLASMS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84872873205     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12049     Document Type: Article

References (29)

1. Toker C,. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105: 107.
2. Moll R, Osborn M, Hartschuh W, Moll I, Mahrle G, Weber K,. Variability of expression and arrangement of cytokeratin and neurofilaments in cutaneous neuroendocrine carcinomas (merkel cell tumors): immunocytochemical and biochemical analysis of twelve cases. Ultrastruct Pathol 1986; 10: 473.
3. Tang CK, Toker C,. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978; 42: 2311.
4. Kuwamoto S,. Recent advances in the biology of merkel cell carcinoma. Hum Pathol 2011; 42: 1063.
5. Buresh CJ, Oliai BR, Miller RT,. Reactivity with TdT in merkel cell carcinoma: a potential diagnostic pitfall. Am J Clin Pathol 2008; 129: 894.
6. Liu Y, Mangini J, Saad R, et al. Diagnostic value of microtubule- associated protein-2 in merkel cell carcinoma. Appl Immunohistochem Mol Morphol 2003; 11: 326.
7. Llombart B, Monteagudo C, Lopez-Guerrero JA, et al. Clinicopathological and immunohistochemical analysis of 20 cases of merkel cell carcinoma in search of prognostic markers. Histopathology 2005; 46: 622.
8. Lumadue JA, Askin FB, Perlman EJ,. MIC2 analysis of small cell carcinoma. Am J Clin Pathol 1994; 102: 692.
9. Moll R, Lowe A, Laufer J, Franke WW,. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427.
10. Nicholson SA, McDermott MB, Swanson PE, Wick MR,. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 2000; 8: 37.
11. Sur M, AlArdati H, Ross C, Alowami S,. TdT expression in merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis. Mod Pathol 2007; 20: 1113.
12. Quttainah A, Thoma A, Salama S,. Clinical-pathological review of 14 cases of merkel cell carcinoma. Can J Plastic Surg 2002; 10: 196.
13. Mount SL, Taatjes DJ,. Neuroendocrine carcinoma of the skin (merkel cell carcinoma). An immunoelectron-microscopic case study. Am J Dermatopathol 1994; 16: 60.
14. Pulitzer MP, Amin BD, Busam KJ,. Merkel cell carcinoma. Adv Anat Pathol 2009; 16: 135.
15. Smith PD, Patterson JW,. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am J Clin Pathol 2001; 115: S68.
16. Feng H, Shuda M, Chang Y, Moore PS,. Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 2008; 319: 1096.
17. Busam KJ, Jungbluth AA, Rekthman N, et al. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 2009; 33: 1378.
18. Buxton D, Bacchi CE, Gualco G, et al. Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 Cases. Am J Clin Pathol 2009; 131: 574.
19. Halliday BE, Slagel DD, Elsheikh TE, Silverman JF,. Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors. Diagn Cytopathol 1998; 19: 410.
20. Gancberg D, Feoli F, Hamels J, et al. Trisomy 6 in merkel cell carcinoma: a recurrent chromosomal aberration. Histopathology 2000; 37: 445.
21. Ambros I, Ambran P, Stehl S, Kovar H, Gadner H, Salze-Kuntschik M,. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 1991; 67: 1886.
22. McCluggage WG, Kennedy K, Busam KJ,. An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol 2010; 34: 525.
23. Guo Y, Yuan F, Deng H, Wang HF, Jin XL, Xiao JC,. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas. Am J Surg Pathol 2011; 35: 799.
24. Li L, Li J, Hao C, et al. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique. Cancer Lett 2011; 310: 9.
25. Makhoul R, Schwartz AM, Williams R, Lee NH,. Paranuclear dot-like immunostaining for CD99: presence in colonic adenomas and adenocarcinomas. Am J Surg Pathol 2011; 35: 1749.
26. Weedon D,. Neural and neuroendocrine tumours. In, Weedon D, ed. Skin pathology, 2nd ed. New York: Churchill-Livingstone, 2002; 990.
27. McCalmont TH,. The revenge of the revenge of the clones. J Cutan Pathol 2011; 38: 607.
28. Quddus MR, Rashid L, Sung CJ, Steinhoff MM, Cunxian Z, Lawrence WD,. Ewing's sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) differentiation in endometrial serous carcinomas. Reprod Sci 2009; 16: 591.
29. Van Gele M, Speleman F, Vandesompele J, Van Roy N, Leonard JH,. Characteristic pattern of chromosomal gains and losses in merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998; 58: 1503.